LYMPHOCYTE-PROLIFERATION IS CONTROLLED BY BOTH IRON AVAILABILITY AND REGULATION OF IRON UPTAKE PATHWAYS

被引:60
作者
SELIGMAN, PA
KOVAR, J
GELFAND, EW
机构
[1] RAYMOND & BEVERLY SACKLER FDN,DENVER,CO
[2] NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,DIV BAS SCI,DENVEN,CO
关键词
TRANSFERRIN RECEPTOR; TRANSFERRIN SYNTHESIS; DEFEROXAMINE; GALLIUM; INDIUM;
D O I
10.1159/000163692
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cell culture data have demonstrated that transferrin, the major iron (Fe) transport protein, is a necessary requirement for cellular proliferation. Evidence suggests that transferrin supports proliferation by providing Fe for critical cellular processes including DNA synthesis. Lymphocytes, similar to other cell types, respond to an increased Fe requirement during proliferation by increased synthesis and expression of surface transferrin receptors. Moreover, under transferrin-Fe-deplete conditions, certain lymphocyte lines exhibit other specialized adaptations that allow for sufficient Fe uptake to support cellular proliferation. These other adaptations include specialized transferrin synthesis and utilization of a transferrin-independent Fe uptake pathway. Lymphocyte proliferation is inhibited by agents that interfere with cellular Fe metabolism; these agents include Fe chelators, class 3a metals that bind to transferrin. and antibodies directed against the transferrin receptor. The data presented in this paper, demonstrate that differences in sensitivity to the effects of these agents are influenced by the amount of available transferrin-Fe and differences in the mechanisms that individual lymphocyte cell lines utilize to ensure adequate Fe uptake to support proliferation. These data support the hypothesis that these agents, if used appropriately, will be useful in the treatment of different lymphoproliferative disorders.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 54 条
[1]  
BECKTON DL, 1988, CANCER RES, V48, P7189
[2]  
BROCK JH, 1986, IMMUNOLOGY, V57, P105
[3]  
BROCK JH, 1989, IRON IMMUNITY CANCER, P81
[4]  
CAROTENUTO P, 1986, J IMMUNOL, V136, P2342
[5]   IRON-RESPONSIVE ELEMENTS - REGULATORY RNA SEQUENCES THAT CONTROL MESSENGER-RNA LEVELS AND TRANSLATION [J].
CASEY, JL ;
HENTZE, MW ;
KOELLER, DM ;
CAUGHMAN, SW ;
ROUAULT, TA ;
KLAUSNER, RD ;
HARFORD, JB .
SCIENCE, 1988, 240 (4854) :924-928
[6]   IMPAIRED IMMUNOCOMPETENCE ASSOCIATED WITH IRON-DEFICIENCY [J].
CHANDRA, RK ;
SARAYA, AK .
JOURNAL OF PEDIATRICS, 1975, 86 (06) :899-902
[7]   LOSS OF EPIDERMAL GROWTH-FACTOR REQUIREMENT AND MALIGNANT TRANSFORMATION [J].
CHERINGTON, PV ;
SMITH, BL ;
PARDEE, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (08) :3937-3941
[8]   EFFECTS OF DIFFERENT TRANSFERRIN FORMS ON TRANSFERRIN RECEPTOR EXPRESSION, IRON UPTAKE, AND CELLULAR PROLIFERATION OF HUMAN-LEUKEMIC HL60 CELLS - MECHANISMS RESPONSIBLE FOR THE SPECIFIC CYTOTOXICITY OF TRANSFERRIN-GALLIUM [J].
CHITAMBAR, CR ;
SELIGMAN, PA .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1538-1546
[9]   REGULATION OF TRANSFERRIN RECEPTOR EXPRESSION ON HUMAN-LEUKEMIC CELLS DURING PROLIFERATION AND INDUCTION OF DIFFERENTIATION - EFFECTS OF GALLIUM AND DIMETHYLSULFOXIDE [J].
CHITAMBAR, CR ;
MASSEY, EJ ;
SELIGMAN, PA .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (04) :1314-1325
[10]  
CHITAMBAR CR, 1987, BLOOD, V69, P144